Filing Details
- Accession Number:
- 0001849521-22-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-17 17:02:01
- Reporting Period:
- 2022-05-16
- Accepted Time:
- 2022-05-17 17:02:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Aspira Women's Health Inc. | AWH | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1849521 | Nicole Sandford | 12117 Bee Caves Rd Bldg 3 Ste 100 Austin TX 78738 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-16 | 98,000 | $0.76 | 136,160 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.745 to $0.779 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
Billionaire Hedge Funds
